Durgical
EN
Open the app

Slow and persistent viral infections

  • General virology

Rare brain and spinal cord diseases that appear years after infection and get steadily worse: SSPE, PML, HTLV-1 myelopathy and prion diseases.

Updated

What it is

Slow infections have a long, silent incubation of months to decades followed by a steadily progressive, usually fatal disease, most often of the nervous system. Some are caused by conventional viruses persisting in an unusual way (measles in SSPE, JC virus in PML, HTLV-1 in myelopathy); prion diseases are caused by a misfolded protein with no nucleic acid. They are compared because they share the time course, not the agent.

Key facts

  • Prions trigger normal prion protein to misfold; they contain no nucleic acid and cause no inflammation or antibody response
  • Prions resist standard heat and chemical sterilization; reusable instruments from suspected cases need special prion protocols
  • SSPE is prevented by measles vaccination; congenital and early-life measles carry the highest risk
  • In HIV-related PML, restoring immunity with antiretroviral therapy is the only measure that improves survival
  • HTLV-1 spreads by breastfeeding, sex, blood and shared needles; most carriers never develop disease

Step by step

  1. Abnormal prion protein arises by chance, from an inherited mutation, or arrives in contaminated tissue, beef, grafts or instruments
  2. It binds normal prion protein made by neurons and refolds it into the abnormal shape
  3. Each new abnormal molecule converts more: a chain reaction with no genes involved
  4. The misfolded protein aggregates, resists breakdown and builds up in the brain
  5. Neurons die and leave small holes (spongiform change) without inflammation
  6. With no fever or antibody response, the disease shows only as rapid dementia, myoclonus and ataxia, and is always fatal

Four slow neurological infections compared

DiseaseAgentWho and whenKey featuresLab and imaging clue
Subacute sclerosing panencephalitis (SSPE)Defective measles virus persisting in brain cellsYears after measles, higher risk after infection in infancyBehaviour and school decline, myoclonus, seizures, deathVery high measles antibodies in CSF; periodic EEG complexes
Progressive multifocal leukoencephalopathy (PML)JC polyomavirus reactivated in oligodendrocytesSevere immunosuppression: advanced HIV, some monoclonal antibodies, blood cancersFocal deficits, ataxia, vision and speech problems; demyelinationMultifocal white matter lesions without mass effect on MRI; JC virus DNA by PCR in CSF
HTLV-1 associated myelopathy / tropical spastic paraparesisHTLV-1 (retrovirus)A small minority of lifelong carriers, after yearsSlowly progressive spastic leg weakness, back pain, bladder dysfunctionHTLV-1 antibodies in serum and CSF
Prion diseases (CJD, variant CJD, kuru, inherited forms)Misfolded prion proteinSporadic in older adults; contaminated beef, instruments or grafts; inherited mutationsRapid dementia, myoclonus, ataxia; always fatalRT-QuIC and 14-3-3 in CSF; MRI diffusion changes; spongiform brain without inflammation

Clinical notes

  • Suspect a slow infection in progressive neurological decline over months with no fever, with the right history (past measles, immunosuppression, endemic area, family history)
  • Colombia: HTLV-1 myelopathy has been described on the Pacific coast; suspected prion disease is reported to the health authority as local rules require

Common traps

  • PML can strike healthy adults: JC virus causes it only with severe immunosuppression (advanced HIV, some monoclonal antibodies, blood cancers).
  • Prion disease shows inflammation in the CSF like other encephalitis: prions cause no inflammation or antibody response; the CSF clues are RT-QuIC and 14-3-3.
  • SSPE follows a badly treated case of measles: it comes from defective virus persisting in the brain for years, with the highest risk after infection in infancy, and measles vaccination prevents it.
  • Standard autoclaving makes instruments from a CJD case safe: prions resist usual heat and chemical sterilization, so special prion protocols are required.
  • Most people with HTLV-1 will develop myelopathy: only a small minority of lifelong carriers do; most never develop disease.

Test yourself

Think of the answer, then tap the question to see it.

A patient with advanced HIV develops weakness, visual loss and speech problems over weeks; MRI shows multifocal white matter lesions without mass effect. What confirms it, and what helps?

PML: JC virus DNA by PCR in the CSF confirms it. Restoring immunity with antiretroviral therapy is the only measure that improves survival.

A 65-year-old has dementia and myoclonus that worsen month by month, with no fever and no inflammatory cells in the CSF. Which CSF tests support prion disease?

RT-QuIC and 14-3-3 protein in the CSF, with diffusion changes on MRI. The absence of inflammation fits, because prions provoke no immune response.

In SSPE the CSF has very high measles antibody levels, yet the virus is never cleared. Why?

The virus is defective and stays inside brain cells, where antibodies cannot reach it; the strong antibody response marks the infection but does not stop it.

A woman from the Colombian Pacific coast has slowly progressive spastic leg weakness and bladder problems. Which virus should be tested for, and how might she have acquired it?

HTLV-1 (HTLV-1 associated myelopathy). It spreads by breastfeeding, sex, blood and shared needles, often decades before the disease.

Why are SSPE, PML, HTLV-1 myelopathy and prion diseases taught together although their agents are so different?

They share the time course: a long silent incubation followed by steady, usually fatal decline of the nervous system.

Add to my cards (5)

Connections

← General microbiology

Educational content on microorganisms; not a treatment guide and no substitute for a health professional's advice. No doses are given.

Sources: Clinical Overview of Measles (CDC, 2025); Progressive multifocal leukoencephalopathy (MedlinePlus, U.S. National Library of Medicine, 2024); Human T-lymphotropic virus-1 (World Health Organization (WHO), 2024); About Prion Diseases (CDC, 2024).

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.